id | C00001743 |
---|---|
Name | Leurosidine |
CAS RN | 15228-71-4 |
Standard InChI | InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37+,38-,39-,42-,43-,44-,45+,46+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 2360 |
By standard InChI | |
---|---|
By standard InChI Main Layer | CHEMBL22969 CHEMBL159 CHEMBL150387 CHEMBL1315323 CHEMBL1437021 CHEMBL1518759 CHEMBL1625660 CHEMBL2311781 |
By LinkDB | C09218 |
---|
By CAS RN |
---|
class name | count |
---|---|
asterids | 1 |
family name | count |
---|---|
Apocynaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Vinca rosea | 4058 | Apocynaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL159 CHEMBL1315323 |
CHEMBL1741321
(1)
CHEMBL1909136
(2)
|
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL1437021 |
CHEMBL1613805
(1)
CHEMBL1614009
(1)
CHEMBL1614293 (1) |
0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL159 |
CHEMBL2077586
(1)
CHEMBL2076374
(1)
CHEMBL2076533 (1) CHEMBL2075738 (1) CHEMBL2077890 (1) |
0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1315323 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL159 |
CHEMBL2169429
(1)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL159 |
CHEMBL2169431
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1437021 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
O95342 | Bile salt export pump | drug | CHEMBL159 |
CHEMBL2076226
(1)
CHEMBL2076242
(1)
|
2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL159 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL159 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL159 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL159 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL159 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL159 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL159 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL159 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL159 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL159 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL159 |
CHEMBL1909197
(2)
|
2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | CHEMBL159 |
CHEMBL993349
(1)
|
0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1315323 |
CHEMBL1614361
(1)
|
3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL159 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL159 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL159 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL159 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL159 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL159 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909093
(2)
|
0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | CHEMBL159 |
CHEMBL910877
(1)
|
0 / 1 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL159 |
CHEMBL754774
(1)
CHEMBL755181
(1)
CHEMBL753510 (1) CHEMBL753511 (1) CHEMBL755826 (1) CHEMBL755827 (1) CHEMBL754160 (1) CHEMBL754161 (1) CHEMBL925479 (1) CHEMBL925480 (1) CHEMBL925481 (1) CHEMBL1108200 (1) CHEMBL1743157 (1) CHEMBL1908285 (1) CHEMBL1908286 (1) CHEMBL1908289 (1) CHEMBL1908291 (1) CHEMBL1908292 (1) CHEMBL2077115 (1) CHEMBL2075099 (1) CHEMBL2076107 (1) CHEMBL2076278 (1) CHEMBL2076682 (1) CHEMBL2076706 (1) CHEMBL2076714 (1) CHEMBL2077346 (1) CHEMBL2077347 (1) CHEMBL2077674 (1) CHEMBL2075621 (1) CHEMBL2076143 (1) CHEMBL2076761 (1) CHEMBL2075231 (1) CHEMBL2075368 (1) CHEMBL2075377 (1) CHEMBL2075383 (1) CHEMBL2075690 (1) CHEMBL2076580 (1) CHEMBL2075280 (1) CHEMBL2076207 (1) CHEMBL2076209 (1) CHEMBL2076213 (1) CHEMBL2076214 (1) CHEMBL2076218 (1) CHEMBL2076241 (1) CHEMBL2076250 (1) CHEMBL2076251 (1) CHEMBL2076066 (1) CHEMBL2078148 (1) CHEMBL2078150 (1) CHEMBL2078576 (1) CHEMBL2078578 (1) CHEMBL2077896 (1) CHEMBL2168297 (1) CHEMBL2168778 (1) |
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL159 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL159 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL159 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL159 CHEMBL1315323 |
CHEMBL1614027
(1)
CHEMBL1741325
(1)
CHEMBL1909135 (2) |
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL159 |
CHEMBL1909203
(2)
|
1 / 11 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL22969 |
CHEMBL1794311
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL159 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL159 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL159 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL159 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL159 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL159 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL159 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL159 |
CHEMBL1909096
(2)
|
1 / 1 |
P07437 | Tubulin beta chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
CHEMBL1012659
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL1315323 |
CHEMBL1613800
(1)
|
0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL159 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL159 |
CHEMBL1909166
(2)
|
1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL159 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1315323 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL22969 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL22969 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL1437021 |
CHEMBL1613838
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL159 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL159 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL159 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL159 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL159 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL159 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL159 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL159 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL159 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL159 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL159 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL159 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL159 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL159 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL159 |
CHEMBL1909119
(2)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL1437021 |
CHEMBL1738610
(1)
|
0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | CHEMBL159 |
CHEMBL2169430
(1)
|
1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL22969 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL159 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL159 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL159 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL159 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL159 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL159 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL159 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL159 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL159 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL159 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL159 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL159 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL159 CHEMBL1315323 |
CHEMBL1613808
(1)
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL159 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL159 CHEMBL1315323 |
CHEMBL1741322
(1)
CHEMBL1909132
(2)
|
0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL159 |
CHEMBL1006005
(1)
CHEMBL2076881
(1)
CHEMBL2077627 (1) CHEMBL2078137 (1) |
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL1437021 |
CHEMBL1738675
(1)
CHEMBL1737868
(1)
|
0 / 0 |
P21439 | Multidrug resistance protein 3 | Enzyme | CHEMBL159 |
CHEMBL1743163
(1)
|
3 / 2 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL159 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL159 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL159 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL159 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL159 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL159 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL159 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL159 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL159 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL159 |
CHEMBL1909168
(2)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1315323 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL159 CHEMBL1315323 |
CHEMBL1741323
(1)
CHEMBL1909134
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL159 CHEMBL1315323 |
CHEMBL664809
(1)
CHEMBL836230
(1)
CHEMBL1614108 (1) CHEMBL1613886 (1) CHEMBL1741324 (1) CHEMBL1743273 (1) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL159 |
CHEMBL1909137
(2)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL22969 |
CHEMBL1794483
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1518759 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
CHEMBL1614502 (1) |
4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1437021 |
CHEMBL1737980
(1)
|
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL159 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL159 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL159 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL159 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL159 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL159 |
CHEMBL1909128
(2)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1437021 |
CHEMBL1794536
(1)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL1315323 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL22969 CHEMBL1437021 CHEMBL1518759 |
CHEMBL1738442
(3)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL22969 |
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL22969 |
CHEMBL1614531
(1)
|
1 / 3 |
Q13748 | Tubulin alpha-3C/D chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
1 / 0 |
P04350 | Tubulin beta-4A chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
2 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
1 / 1 |
P68371 | Tubulin beta-4B chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
2 / 1 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | CHEMBL159 |
CHEMBL815200
(1)
|
1 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 |
O95342
|
#614972 | Cholestasis, intrahepatic, of pregnancy 3; icp3 |
P21439
|
#601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 |
O95342
|
#602347 | Cholestasis, progressive familial intrahepatic, 3; pfic3 |
P21439
|
#114500 | Colorectal cancer; crc |
P84022
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#600803 | Gallbladder disease 1; gbd1 |
P21439
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00624 | Familial cholestasis |
O95342
(related)
P21439 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
P04637 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01213 | Gallbladder disease |
P21439
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|